Items Tagged ‘cardiac regeneration’

October 29, 2020

Long-term safety, benefits of stem therapy for heart failure

By Susan Buckles Susan Buckles (@susanbuckles)

The largest regenerative medicine clinical trial to date for heart failure finds stem cell therapy is safe over the long term and benefits patients with advanced left ventricular enlargement. This multinational research, co-led by Andre Terzic, M.D., Ph.D., director of Mayo Clinic’s Center for Regenerative Medicine, and published in ESC Heart Failure, offers guidance in […]

View full entry

Tags: cardiac regeneration, cardiopoietic stem cells, CHART-1 Trial, Dr. Andre Terzic, heart disease, Mayo Clinic Center for Regeneration, stem cell therapy

February 14, 2020

Evolution of cardiac regeneration

By Jen Schutz Jen Schutz (@jenniferschutz)

February is American Heart Month, a time to acknowledge advancements in a new generation of care. This year focus is placed on repairing damaged heart tissue and restoring heart function after a heart attack. The Mayo Clinic Center for Regenerative Medicine is leading research into cardiac regeneration. Accounting for nearly 20 million of all deaths, […]

View full entry

Tags: #American Heart Month, #Dr. Michael Sabbah, cardiac regeneration, Dr. Atta Behfar, heart attack, heart disease, Mayo Clinic Center for Regenerative Medicine

January 4, 2018

Researching Cell-Free Peptide Therapeutics for Cardiac Repair and Regeneration

By centerforregmedmc centerforregmedmc (@centerforregmedmc)

John C. Burnett Jr., M.D., is studying the prevention of heart failure after a heart attack. The goal of his research is to establish that the use of a novel Mayo Clinic engineered peptide will serve as a cell-free therapeutic strategy for cardiac repair and regeneration. Dr. Burnett is a Regenerative Medicine Minnesota research grant recipient […]

View full entry

Tags: cardiac regeneration, Center for Regenerative Medicine, Dr. John Burnett, Mayo Clinic, Medical Research, regenerative medicine, stem cells

December 7, 2017

Mayo Clinic, Children’s Minnesota Announce Congenital Heart Defect Collaboration

By centerforregmedmc centerforregmedmc (@centerforregmedmc)

This story first appeared on the Mayo Clinic News Network. Mayo Clinic’s Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome and Children’s Minnesota are collaborating to prevent heart failure for hypoplastic left heart syndrome, a rare and complex form of congenital heart disease in which the left side of a child’s heart […]

View full entry

Tags: cardiac regeneration, Center for Regenerative Medicine, Congenital Heart Disease, HLHS, hypoplastic left heart syndrome, mayo clinic medical research, regenerative medicine, stem cells, Timothy Nelson

January 10, 2017

Regenerative Medicine has Potential to Change How We Approach Cardiovascular Disease

By centerforregmedmc centerforregmedmc (@centerforregmedmc)

An article in Cardiology News describes the effort to bring regenerative medicine into clinical practice for cardiovascular disease. Although routine stem cell applications for cardiovascular disease are not yet available, current research spans the spectrum of heart diseases, deepening our knowledge base. This new knowledge is translating into a regenerative medicine care that moves towards […]

View full entry

Tags: Andre Terzic, cardiac regeneration, cardiovascular disease, Mayo Clinic research, Medical Research, research, stem cells

September 29, 2016

Mayo Clinic Researchers Investigate Innovations in Heart Transplant

By centerforregmedmc centerforregmedmc (@centerforregmedmc)

Previously published in Mayo Clinic’s research magazine, Discovery’s Edge. As a science writer, I’m typically juggling a recorder, a note pad and a pen. Sometimes a camera. Today, the heart I held in my hand was warm and firm, red and healthy-looking. And beating. In my hand. Just an hour earlier it was in the […]

View full entry

Tags: Atta Behfar, cardiac regeneration, Mayo Clinic, regenerative medicine, research, stem cells

January 21, 2014

Mayo Clinic Discovery Leads to FDA Approval for Stem Cell Trial for Heart Failure Patients

By centerforregmedmc centerforregmedmc (@centerforregmedmc)

Cardio3 BioSciences, an international Mayo Clinic collaborator, has received FDA approval for a phase III pivotal clinical trial of its stem cell therapy. The trial will test the Mayo Clinic discovery of cardiopoietic (cardiogenically-instructed) stem cells designed to improve heart health in people suffering from heart failure. The multisite U.S. trial, called CHART-2, will aim to recruit […]

View full entry

Tags: Andre Terzic, Atta Behfar, cardiac regeneration, Cardio3 Biosciences, European stem cell trial, heart disease, Mayo Clinic, regenerative medicine, stem cells

Contact Us · Privacy Policy